Evidence map›Paper›PMID 37988898›Full record

ArticleBiomaterials2023

Engineering large and geometrically controlled vascularized nerve tissue in collagen hydrogels to restore large-sized volumetric muscle loss.

Shih-Yen Wei, Po-Yu Chen, Chia-Chang Hsieh, Yu-Shan Chen, Tzu-Hsuan Chen, Yu-Shan Yu, Min-Chun Tsai, Ren-Hao Xie, Guan-Yu Chen, Gung-Chian Yin and 2 more

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Multifunctional scaffold based on TiMaterials today. Bio · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Shih-Yen WeiDepartment of Materials Science and Engineering, National Tsing-Hua University, Hsinchu, Taiwan.
Po-Yu ChenDepartment of Materials Science and Engineering, National Tsing-Hua University, Hsinchu, Taiwan.
Chia-Chang HsiehDepartment of Materials Science and Engineering, National Tsing-Hua University, Hsinchu, Taiwan.
Yu-Shan ChenDepartment of Materials Science and Engineering, National Tsing-Hua University, Hsinchu, Taiwan.
Tzu-Hsuan ChenDepartment of Materials Science and Engineering, Carnegie Mellon University, PA, USA.
Yu-Shan YuDepartment of Materials Science and Engineering, National Tsing-Hua University, Hsinchu, Taiwan.
Min-Chun TsaiDepartment of Materials Science and Engineering, National Tsing-Hua University, Hsinchu, Taiwan.
Ren-Hao XieDepartment of Electrical and Computer Engineering, College of Electrical and Computer Engineering, National Yang Ming Chiao Tung University, Hsinchu, Taiwan; Institute of Biomedical Engineering, College of Electrical and Computer Engineering, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
Guan-Yu ChenDepartment of Electrical and Computer Engineering, College of Electrical and Computer Engineering, National Yang Ming Chiao Tung University, Hsinchu, Taiwan; Institute of Biomedical Engineering, College of Electrical and Computer Engineering, National Yang Ming Chiao Tung University, Hsinchu, Taiwan; Department of Biological Science and Technology, National Yang Ming Chiao Tung University, Hsinchu, Taiwan; Center for Intelligent Drug Systems and Smart Bio-devices (IDS2B), National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
Gung-Chian YinNational Synchrotron Radiation Research Center, Hsinchu, Taiwan.
Juan M Melero-MartinDepartment of Cardiac Surgery, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; Department of Surgery, Harvard Medical School, Boston, MA, USA; Harvard Stem Cell Institute, Cambridge, MA, USA.
Ying-Chieh ChenDepartment of Materials Science and Engineering, National Tsing-Hua University, Hsinchu, Taiwan. Electronic address: yisschen@mx.nthu.edu.tw.
National Tsing Hua University · TWNational Yang Ming Chiao Tung University · TWBoston Children's Hospital · US

Funding

Vascular networks genetically engineered for protein drug deliveryR01HL128452 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M, WANG, BO · 2015 to 2024
$4.8M
Vascular niche bioengineering for human bone regenerationR01AR069038 · NIAMS · BOSTON CHILDREN'S HOSPITAL · PI MELERO-MARTIN, JUAN M · 2016 to 2020
$1.9M
NHLBI NIH HHS R01 HL128452NIAMS NIH HHS R01 AR069038
6 · The paper itself

Abstract

Developing scalable vascularized and innervated tissue is a critical challenge for the successful clinical application of tissue-engineered constructs. Collagen hydrogels are extensively utilized in cell-mediated vascular network formation because of their naturally excellent biological properties. However, the substantial increase in hydrogel contraction induced by populated cells limits their long-term use. Previous studies attempted to mitigate this issue by concentrating collagen pre-polymer solutions or synthesizing covalently crosslinked collagen hydrogels. However, these methods only partially reduce hydrogel contraction while hindering blood vessel formation within the hydrogels. To address this challenge, we introduced additional support in the form of a supportive spacer to counteract the contraction forces of populated cells and prevent hydrogel contraction. This approach was found to promote cell spreading, resist hydrogel contraction, control hydrogel/tissue geometry, and even facilitate the engineering of functional blood vessels and host nerve growth in just one week. Subsequently, implanting these engineered tissues into muscle defect sites resulted in timely anastomosis with the host vasculature, leading to enhanced myogenesis, increased muscle innervation, and the restoration of injured muscle functionality. Overall, this innovative strategy expands the applicability of collagen hydrogels in fabricating large vascularized nerve tissue constructs for repairing volumetric muscle loss (∼63 %) and restoring muscle function.

Indexed as

HydrogelsNerve TissueCollagenMusclesTissue EngineeringCollagenHydrogelsCell-populated hydrogelCollagen hydrogel contractionMuscle repairVascular tissue engineeringVolumetric muscle loss

Identifiers

PMID37988898
PMCPMC11606314
OpenAlexW4388687029

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.